• Markets
• News
• Learn

U.S. stock futures were higher this morning, with the Dow futures gaining more than 150 points on Monday.

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) fell sharply in today's pre-market trading after the company suspended ELEVIDYS shipments and paused ENVISION trial after second fatal liver failure in non-ambulatory Duchenne patients.

Sarepta Therapeutics shares tumbled 31.4% to $24.86 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

• KULR Technology Group, Inc. (NYSE:KULR) shares fell 21.9% to $0.8980 in pre-market trading after the company reported a 1-for-8 reverse stock split.
• Gold Royalty Corp. (NYSE:GROY) dipped 14.7% to $1.95 in pre-market trading. Canaccord Genuity, on June 11, initiated a Buy rating on the stock and announced a $3 price target.
• Solid Biosciences Inc. (NASDAQ:SLDB) fell 8% to $4.15 in pre-market trading. JMP Securities, on June 6, reiterated its Market Outperform rating on the stock and maintained a $15 price target.
• Omada Health, Inc. (NASDAQ:OMDA) fell 5.4% to $16.18 in pre-market trading.
• Repligen Corporation (NASDAQ:RGEN) declined 4% to $122.50 in pre-market trading.
• IonQ, Inc. (NYSE:IONQ) slipped 3.2% to $36.65 in pre-market trading.
• Tango Therapeutics, Inc. (NASDAQ:TNGX) declined 3.2% to $4.54 in pre-market trading.

Now Read This:

• Top 2 Energy Stocks That May Fall Off A Cliff in June

Photo via Shutterstock